Erysipelas physical examination

	Erysipelas Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Erysipelas from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Electrocardiogram
X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Erysipelas physical examination On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Erysipelas physical examination All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Erysipelas physical examination
CDC on Erysipelas physical examination
Erysipelas physical examination in the news
Blogs on Erysipelas physical examination
Directions to Hospitals Treating Erysipelas
Risk calculators and risk factors for Erysipelas physical examination

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Luke Rusowicz-Orazem, B.S., Kiran Singh, M.D. [2]

Overview

Erysipelas manifests with a characteristic rash, localized on the epidermis. Signs include erythema, edema, bullae, vesicles, and blebs. It usually manifests on the legs, but can also be found on the face, torso, hands, feet, and toes. The patient may also be ill-appearing if there is presence of systemic illness, such as fever, chills, or vomiting.

Physical Examination

Appearance of the Patient

The patient may be ill-appearing if systemic illness such as fever, chills, or vomiting is present.^[1]

Vital signs

Fever may be present in erysipelas patients.

Skin

Erysipelas manifests with a characteristic rash, localized on the epidermis, with the following presentation:^[2]

Erythema
Edema
Sharp, demarcated edges between inflamed and normal tissue
Bullae
Vesicles^[3]
Blebs^[4]

Extremities

Erysipelas is most commonly found in the leg.^[5]

Secondarily, it is found on the face, as well as torso, toes, feet, and hands.^[6]

Examples of Physical Examination Findings for Erysipelas

References

↑ {{cite journal |vauthors=Inghammar M, Rasmussen M, Linder A |title=Recurrent erysipelas--risk factors and clinical presentation |journal=BMC Infect. Dis. |volume=14 |issue= |pages=270 |year=2014 |pmid=24884840 |pmc=4033615 |doi=10.1186
↑ Bläckberg A, Trell K, Rasmussen M (2015). "Erysipelas, a large retrospective study of aetiology and clinical presentation". BMC Infect. Dis. 15: 402. doi:10.1186/s12879-015-1134-2. PMC 4590694. PMID 26424182.
↑ Chong FY, Thirumoorthy T (2008). "Blistering erysipelas: not a rare entity". Singapore Med J. 49 (10): 809–13. PMID 18946616.
↑ Ferretti JJ, Stevens DL, Fischetti VA, Stevens DL, Bryant AE. PMID 26866211. Missing or empty |title= (help)
↑ Bernard P, Chosidow O, Vaillant L (2002). "Oral pristinamycin versus standard penicillin regimen to treat erysipelas in adults: randomised, non-inferiority, open trial". BMJ. 325 (7369): 864. PMC 129632. PMID 12386036.
↑ Krasagakis K, Samonis G, Maniatakis P, Georgala S, Tosca A (2006). "Bullous erysipelas: clinical presentation, staphylococcal involvement and methicillin resistance". Dermatology (Basel). 212 (1): 31–5. doi:10.1159/000089019. PMID 16319471.
↑ ^7.00 ^7.01 ^7.02 ^7.03 ^7.04 ^7.05 ^7.06 ^7.07 ^7.08 ^7.09 ^7.10 ^7.11 ^7.12 ^7.13 ^7.14 ^7.15 ^7.16 ^7.17 ^7.18 ^7.19 ^7.20 ^7.21 ^7.22 ^7.23 ^7.24 ^7.25 ^7.26 ^7.27 ^7.28 ^7.29 ^7.30 ^7.31 ^7.32 ^7.33 ^7.34 ^7.35 ^7.36 "Dermatology Atlas".

Template:WH Template:WS

[pmid24884840-1] {{cite journal |vauthors=Inghammar M, Rasmussen M, Linder A |title=Recurrent erysipelas--risk factors and clinical presentation |journal=BMC Infect. Dis. |volume=14 |issue= |pages=270 |year=2014 |pmid=24884840 |pmc=4033615 |doi=10.1186

[pmid26424182-2] Bläckberg A, Trell K, Rasmussen M (2015). "Erysipelas, a large retrospective study of aetiology and clinical presentation". BMC Infect. Dis. 15: 402. doi:10.1186/s12879-015-1134-2. PMC 4590694. PMID 26424182.

[pmid18946616-3] Chong FY, Thirumoorthy T (2008). "Blistering erysipelas: not a rare entity". Singapore Med J. 49 (10): 809–13. PMID 18946616.

[pmid26866211-4] Ferretti JJ, Stevens DL, Fischetti VA, Stevens DL, Bryant AE. PMID 26866211. Missing or empty |title= (help)

[pmid12386036-5] Bernard P, Chosidow O, Vaillant L (2002). "Oral pristinamycin versus standard penicillin regimen to treat erysipelas in adults: randomised, non-inferiority, open trial". BMJ. 325 (7369): 864. PMC 129632. PMID 12386036.

[pmid16319471-6] Krasagakis K, Samonis G, Maniatakis P, Georgala S, Tosca A (2006). "Bullous erysipelas: clinical presentation, staphylococcal involvement and methicillin resistance". Dermatology (Basel). 212 (1): 31–5. doi:10.1159/000089019. PMID 16319471.

[Dermatology_Atlas-7] 7.00 ^7.01 ^7.02 ^7.03 ^7.04 ^7.05 ^7.06 ^7.07 ^7.08 ^7.09 ^7.10 ^7.11 ^7.12 ^7.13 ^7.14 ^7.15 ^7.16 ^7.17 ^7.18 ^7.19 ^7.20 ^7.21 ^7.22 ^7.23 ^7.24 ^7.25 ^7.26 ^7.27 ^7.28 ^7.29 ^7.30 ^7.31 ^7.32 ^7.33 ^7.34 ^7.35 ^7.36 "Dermatology Atlas".

[1]

[2]

[3]

[4]

[5]

[6]

[7]

Erysipelas physical examination

Overview

Physical Examination

Appearance of the Patient

Vital signs

Skin

Extremities

Examples of Physical Examination Findings for Erysipelas

Extremities

Trunk

Face

References

Navigation menu

Search